Sponsor Pipeline

First Institute of All Medicines Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06147999 Impact of a Biophoton Therapy on Patients With Brain Disorders Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury Recruiting
NCT06915012 Impact of Biophoton Therapy on Chronic Severe Arthritis Pain Arthritis Recruiting
NCT07124208 RCT to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes Type 2 Diabetes Not Yet Recruiting
Disease Areas
Alzheimer's Disease (1) Dementia (1) Parkinson's Disease (1) Type 2 Diabetes (1) Diabetes (1)
Get alerts when First Institute of All Medicines's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free